Performances of Elasto-FibroTest®, a combination between FibroTest® and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 5, 2012, Pages 455-463

  Poynard, Thierry ^a   de Ledinghen, Victor ^b   Zarski, Jean Pierre ^c   Stanciu, Carol ^d   Munteanu, Mona ^e   Vergniol, Julien ^b   France, Julie ^f   Trifan, Anca ^d   Lenaour, Gilles ^a   Vaillant, Jean Christophe ^a   Ratziu, Vlad ^a   Charlotte, Frederic ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c Clinique Universitaire d'Hépato gastroentérologie   (France)

^d Gastroenterology and hepatology institute   (Romania)

^e CHU de Grenoble ^*

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER EXAMINATION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84868359857     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.08.002     Document Type: Article

References (36)

1. Castera L., Pinzani M. Non-invasive assessment of liver fibrosis: are we ready?. Lancet 2010, 375:1419-1420.
2. Nguyen D., Talwalkar J.A. Non-invasive assessment of liver fibrosis. Hepatology 2011, 53:2107-2110.
3. Poynard T. First line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy. J Hepatol 2011, 54:586-587.
4. ®, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
5. Sebastiani G., Halfon P., Castera L., Pol S., Thomas D.L., Mangia A., et al. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009, 49:1821-1827.
6. ® improves the non-invasive diagnosis of liver fibrosis. Liver Int 2009, 29:1507-1515.
7. ® for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2011, 106:1255-1263.
8. Boursier J., de Ledinghen V., Zarski J.P., Fouchard-Hubert I., Gallois Y., Oberti F., et al. Comparison of 8 diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely non-invasive. Hepatology 2012, 55:58-67.
9. Poynard T., Ingiliz P., Elkrief L., Munteanu M., Lebray P., Morra R., et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008, 3:e3857.
10. Castéra L., Foucher J., Bernard P.H., Carvalho F., Allaix D., Merrouche W., et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010, 51:828-835.
11. ® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate. Clin Res Hepatol Gastroenterol 2011, 35:720-730.
12. Rutjes A.W., Reitsma J.B., Coomarasamy A., Khan K.S., Bossuyt P.M. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess 2007, 11:1-51.
13. ® and biopsy for assessing the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol 2012, 56:541-548.
14. Bedossa P., Dargère D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
15. Poynard T., Lenaour G., Vaillant J.C., Capron F., Munteanu M., Eyraud D., et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol 2012, 10:657-663. [Epub ahead of print].
16. Rousselet M.C., Michalak S., Dupré F., Croué A., Bedossa P., Saint-André J.P., et al. Hepatitis Network 49. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005, 41:257-264.
17. Mehta S.H., Lau B., Afdhal N.H., Thomas D.L. Exceeding the limits of liver histology markers. J Hepatol 2009, 50:36-41.
18. ®. A reappraisal at 7years of age. BMC Gastroenterol 2011, 11:39.
19. La Haute Autorité de santé (HAS) in France - The HAS recommendations for the management of the chronic hepatitis C using non-invasive biomarkers. (Accessed August 2007). http://www.has-sante.fr/portail/display.jsp?id=c_476486.
20. Friedrich-Rust M., Ong M.F., Martens S., Sarrazin C., Bojunga J., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974.
21. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
22. Qu Y., Tan M., Kutner M.H. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics 1996, 52:797-810.
23. Hadgu A., Qu Y. A biomedical application of latent class models with random effects. Appl Stat 1998, 47:603-616.
24. Vermunt JK, Magidson J. Technical Guide to Latent Gold 4.5. Belmont Massachusetts: Statistical Innovations 2007; Inc. Latent Gold 4.5, Statistical Innovation, Belmont, MA, USA.
25. Zhou X., Obuchowski N., McClish D. Statistical Methods in Diagnostic Medicine 2002, John Wiley and Sons, Noboken, NJ, USA.
26. Lambert J., Halfon P., Penaranda G., Bedossa P., Cacoub P., Carrat F. How to measure the diagnostic accuracy of non-invasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008, 54:1372-1378.
27. Hintze JL. NCSS 2007 User Guide. Number Cruncher Statistical Systems software NCSS, Kaysville, Utah 2007.
28. Zarski J.P., Sturm N., Guechot J., Paris A., Zafrani E.S., Asselah T., et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012, 56:55-62.
29. Vergniol J., Foucher J., Terrebonne E., Bernard P.H., Le Bail B., Merrouche W., et al. Non-invasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011, 140:1970-1979.
30. Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071148.htm.
31. ®) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009, 49:1083-1089.
32. Myers R.P., Crotty P., Pomier-Layrargues G., Ma M., Urbanski S.J., Elkashab M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 2010, 30:1471-1480.
33. Munteanu M., Ratziu V., Poynard T. The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis test. Am J Gastroenterol 2011, 106:1853.
34. ®) for assessing liver fibrosis progression: proof of concept and first application in a large population. J Hepatol 2012, 57:541-548. [Epub ahead of print].
35. Poynard T., Ngo Y., Perazzo H., Munteanu M., Lebray P., Moussalli J., et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol 2011, 7:445-454.
36. ®). BMC Gastroenterol 2010, 10:40.